No Picture
News

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

SAN DIEGO and SHANGHAI, May 15, 2022 /PRNewswire/ — Inmagene Biopharmaceuticals (“Inmagene”) announces that today the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate IMG-004, a […]

No Picture
News

Pfizer’s $11.6B wager; TIGIT implosion; An unusual pharma-biotech pact; Inside a16z’s vision to reshape biotech; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

No Picture
News

Hydralyte Announces Investment and Brand Collaboration with Actress and Entrepreneur, Shay Mitchell

SAN DIEGO, May 13, 2022 /PRNewswire/ — Today Hydralyte, one of the world’s most trusted rapid hydration solutions, announces a multi-year collaborative partnership with actress, producer and entrepreneur, Shay Mitchell. Mitchell joins the Hydralyte team […]